AzTrials
AzTrials

Amputation of Lower Limb Below KneeNCT05265403

Evaluation of High-Performance, Customized, Rapidly-Manufacturable Prosthetic Feet That Provide Improved Mobility

An observational study of Amputation of Lower Limb Below Knee, run by Massachusetts Institute of Technology at 1 site in United States.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The purpose of this research is to design a high-performance, customized, and rapidly- manufacturable passive prosthetic foot for use in the United States. We are currently testing an early stage prototype and would like user input before pursuing additional clinical testing. Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Amputation of Lower Limb Below Knee
What is being tested?
Commercially-available energy storage and return prosthetic foot and MIT-Lower Leg Trajectory Error (LLTE) customized prosthetic feet
Type of treatment
Medical device
How many people
40 participants
Where
1 siteUnited States
Study dates
3 Mar 2022to 31 Aug 2022
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Subjects with a unilateral transtibial amputation will be recruited through the Hanger Clinic. Subjects will likely be recruited who live in the Salt Lake City, Utah area, where data will be collected. Potential subjects will be screened to ensure that they satisfy the inclusion criteria. Screening will take place during the recruitment process either in person at the clinic or when the subject makes contact with the investigator. Subjects will be asked questions to ensure they meet the study inclusion criteria.

Who may be able to join

  • Unilateral transtibial amputation
  • Aged between 18-65 years
  • Body mass index between 18.5-29.9 (healthy weight)
  • Daily use of their clinically-prescribed prosthesis for ambulation without an assistive device
  • Classified as at least a Medicare Functional Classification Level K3 (defined as a patient who is a typical unlimited community ambulator)
  • Experience walking with a prosthesis for at least one year
Show all 9Show fewer
  • Residuum and amputated side in good condition (e.g., no adherent scars, lesions, ulcers, or infections)
  • Normal or corrected vision
  • Ability to walk continuously for 45 minutes without undue fatigue or health risks.

Who cannot join

  • Subjects who weigh more than 200 pounds
  • Poor fitting prosthetic socket
  • Skin problems on the residual limb
  • Co-morbidities or pathologies (other than the amputation) or medications that would affect the sound limb, spine, balance, or stability
  • Decision by prosthetists at Hanger that walking on the prototype limb may pose higher than minimal risk for a potential subject.

Trial locations and contacts

1 site in 1 country.

Charlotte M Folinus, SB contact

4042451422

cfolinus@mit.edu

United States1 site, 1 recruiting
  • Hanger Clinic

    Salt Lake City, Utah, 84109

    Phil Stevens, MEd, CPO, 385-419-3610, pstevens@hanger.com

    Recruiting

Other trials in United States

About this study

The purpose of this research is to design a high-performance, customized, and rapidly- manufacturable passive prosthetic foot for use in the United States. We are currently testing an early stage prototype and would like user input before pursuing additional clinical testing. Participants will be asked about their current prosthesis type and use, amputation side and cause, and activity level. We will take measurements of height, weight, and length of the participant's residual limb. The participant will be asked to walk in several prosthetic foot conditions in multiple walking activities, and the visit should last approximately four hours.

For each prosthetic foot, a trained prosthetist will fit the foot (either a prototype foot or a commercially available K3/K4 foot) to the prosthesis. The patient will then walk around the room until they feel comfortable. They may initially walk using a gait belt or between parallel bars based on comfort level and an evaluation by the prosthetist. Once they feel comfortable walking on level ground at a normal speed and the prosthetist feels that they will be safe performing more challenging walking activities, the participant will perform different walking activities (such as walking on flat ground at different speeds, walking up/down ramps, and walking up/down stairs). They will then be asked to tell the investigator what they like and dislike about the prosthetic foot.

Read the detailed description

The purpose of this research is to design a high-performance, customized, and rapidly- manufacturable passive prosthetic foot for use in the United States. We are currently testing an early stage prototype and would like your input before pursuing additional clinical testing. The Global Engineering and Research (GEAR) Laboratory at the Massachusetts Institute of Technology (MIT) has developed a novel design framework for creating high-performance, passive prosthetic feet. By incorporating commercial aesthetic and functional requirements, we hypothesize that we can use this design methodology to create high-performance prosthetic feet that can be customized and provided at scale in the United States.

Participants will be asked about their current prosthesis type and use, amputation side and cause, and activity level. We will take measurements of height, weight, and length of the participant's residual limb. The participant will be asked to walk in several prosthetic foot conditions in multiple walking activities, and the visit should last approximately four hours.

For each prosthetic foot, a trained prosthetist will fit the foot (either a prototype foot or a commercially available K3/K4 foot) to the prosthesis. The patient will then walk around the room until they feel comfortable. They may initially walk using a gait belt or between parallel bars based on comfort level and an evaluation by the prosthetist. Once they feel comfortable walking on level ground at a normal speed and the prosthetist feels that they will be safe performing more challenging walking activities, the participant will perform different walking activities (such as walking on flat ground at different speeds, walking up/down ramps, and walking up/down stairs). They will then be asked to tell the investigator what you like and dislike about the prosthetic foot.

Participants may also be asked to walk while wearing inertial measurement units (IMU's), which are wearable devices similar in size to a pedometer or wrist watch. These devices will record the acceleration of the limbs, which will allow us to understand how people walk in the different prosthetic feet. We will attach the IMU's using their elastic bands, and we will attach necessary wires with hypoallergenic tape. Wearing the IMU's, the participant will walk back and forth in the room while the sensors record information about how you are walking. They may rest at any time.

Being tested
Commercially-available energy storage and return prosthetic foot, MIT-Lower Leg Trajectory Error (LLTE) customized prosthetic feet
Keywords
transtibial amputation, below knee amputation, prosthetic device design, biomechanics

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Commercially-available energy storage and return prosthetic footDrug

    Also called Freedom Highlander

    Each patient will walk in the Freedom Highlander, a commercially-available energy storage and return prosthetic foot. The foot will be sized based on the patient's foot size and weight.

  • MIT-Lower Leg Trajectory Error (LLTE) customized prosthetic feetDevice

    Each patient will walk in prosthetic feet designed by the researchers at MIT. These feet will be customized for the user based on their body size (ie, height, foot length) and weight.

Study groups in NCT05265403
Study groupRoleWhat they receive
Below knee amputeesAdult, unilateral trans-tibial amputees (amputation is below the knee and only on one side) who will wear and test our prototype prosthetic feet
Receives: Drug: Commercially-available energy storage and return prosthetic foot; Device: MIT-Lower Leg Trajectory Error (LLTE) customized prosthetic feet

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number of patients who prefer each prosthetic foot tested for each walking activity

    For each walking activity, subjects will qualitatively select which foot option they prefer for each activity (ie, standing, walking at varied speeds on level ground, and walking up/down ramps). Subjects will provide this information through a questionnaire where they indicate their preferred foot for each activity.

    Measured: At the end of study completion, after ~4 hours of total time on a single day to acclimate to all prosthetic feet tested

  2. Mean difference in prosthetic foot evaluation score between prototype prosthetic feet and commercial prosthetic feet, as assessed by a self-reported questionnaire

    For each prosthetic foot, patients will fill out a questionnaire, which is a modified form of the standardized prosthesis evaluation questionnaire (PEQ). The PEQ is a clinically-validated, self-report questionnaire used to assess the prosthesis and life with the prosthesis.

    Questions are evaluated on a Likert scale (ie, "Strongly disagree" to "Strongly agree") which will be converted to numerical values. A low score represents a poor rating (the patient did not like the device) and a high score represents a strong rating.

    The overall outcome measure is the difference in total score (totaled across all questions) between each foot condition. The score for an individual foot represents an overall evaluation of that prosthesis, which we will average across participants and compare between feet. The difference in scores evaluates the feasibility of the prototype foot compared with the subject's own, daily-use prosthesis as well as the commercially available control prosthetic foot.

    Measured: At the end of study completion, after ~4 hours of total time on a single day to acclimate to all prosthetic feet tested

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Mar 2022
  2. Study start3 Mar 2022
  3. Primary completion30 Jul 2022 (estimated)
  4. Study completion31 Aug 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Cross-sectional
Enrolment
40 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05265403
Sponsor's protocol ID
2106000399
Status last verified
Feb 2022
First submitted
26 Jan 2022
Last updated
12 Apr 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: The aggregated data will be kept for several years in order to compare the performance of this prototype with the performance of future prototypes. Data collected will be subjective feedback, information about prosthetic foot alignment, and biomechanical data about walking patterns, none of which is particularly sensitive. While participant data is not particularly sensitive, it pertains to intellectual property of new prosthetic foot designs, and we will not be making the individual participant data (IPD) available to other researchers.

Questions about this trial

What is this clinical trial studying?

An observational study of Amputation of Lower Limb Below Knee, run by Massachusetts Institute of Technology at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 12 Apr 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Charlotte M Folinus, SB (4042451422, cfolinus@mit.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number of patients who prefer each prosthetic foot tested for each walking activity (time frame: At the end of study completion, after ~4 hours of total time on a single day to acclimate to all prosthetic feet tested). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Apr 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in